baber/WOPTO huggingface dataset:
Patent CA-2538854-A1 (CA)
Title: Method and system for suppression of features in pages of content
Inventor: BEZOS JEFFREY
IPC: G06K9/34
Filed: 2004-09-23
Abstract: Suppression of one or more features in an image of a page of content may be achieved by acquiring a page image (123), identifying one or more features i n the page image (124) that are to be suppressed (126) or not to be suppressed , and preparing a substitute page image which only includes images of the features that are not to be suppressed (128). Preparing a substitute page image may include generating a blank image and using location and size information to copy images of the non-suppressed features from the original page image to the blank image. In other embodiments, preparing a substitute page image may include removing image information from the original page ima ge outside the non-suppressed features, or identifying and removing features th at are to be suppressed from the original page image.
Patent CA-2538956-A1 (CA)
Inventor: ARNDT WOLFGANG
IPC: C08G18/70
Filed: 2004-09-07
Abstract: The invention relates to polyurethane-based aqueous polymer dispersions which comprise a) a polyurethane dispersion having an average particle size of from 60 to 350 nm and b) an aqueous silica dispersion having a particle diameter of the SiO2 particles of from 20 to 400 nm. The invention also relates to a method for producing the inventive dispersions and to the use thereof.
Patent CA-2541675-A1 (CA)
Title: Method and apparatus for wireless pc tablet presentation process
Inventor: WACO DAVID
IPC: G06Q50/10
Filed: 2006-04-04
Abstract: In one embodiment, the disclosure relates to a method for providing a customer with repair information for a vehicle at a point of service. The method includes (1) identifying the vehicle by using a vehicle identifier, the vehicle identifier defined by at least one of a vehicle identification number, manufacturer, model, year of production and owner; (2) identifying a preliminary assessment of the vehicle; (3) providing a first presentation, the first presentation defined by at last one of the vehicle identifier, a vehicle repair history and the preliminary assessment of the vehicle; (4) providing a second presentation, the second presentation directed to a recommended service plan; (5) each of the first presentation and the second presentation allowing the customer to select or decline one or more services offered by each presentation; and (6) identifying a customer-declined service and providing the customer at least one of a reminder or an incentive for future use of the declined service.
Patent CA-2543095-A1 (CA)
Inventor: NOGRE MICHEL
IPC: C07K1/34
Filed: 2004-10-25
Abstract: La présente invention se rapporte à une composition de Facteur VIII d~origine plasmatique sécurisé viralement, obtenue après filtration nanométrique, comprenant du Facteur von Willebrand (FvW) à un taux inférieur ou égal à 15 %  des décamères et multimères supérieurs. De telles compositions présentent un facteur de réduction du titre des virus supérieur à 4 log et sont donc adaptées pour le traitement de l~hémophilie.
Patent CA-2543172-A1 (CA)
Title: Stable lansoprazole formulation
Inventor: AVRAMOFF AVI
IPC: A61K9/20
Filed: 2004-11-01
Abstract: A stable composition comprising a substrate comprising lansopraxole (preferably in the base form), without any alkaline agent; a subcoating layer containing alkaline agent; and an enteric coating layer. The substrate is preferably as inert core with an active layer (containing lansopraxole) layered over it.
Patent CA-2545651-A1 (CA)
Inventor: BOUCHER RYAN P
IPC: A61F5/56
Filed: 2004-11-16
Abstract: Devices, systems and methods develop static and/or kinetic and/or pressure forces to fixate or brace tissue in targeted pharyngeal structures and individual anatomic components within the pharyngeal conduit.
Patent CA-2547059-A1 (CA)
Title: Methods and kits related to administration of a fructooligosaccharide
Inventor: VICKERS ROBERT JASON
IPC: A23K1/18
Filed: 2004-12-01
Abstract: A first embodiment disclosed herein is a method of enhancing total tract digestibility of one or more dietary components in a companion animal, the method comprising administering to the companion animal a companion animal composition comprising fructooligosaccharide. Kits comprising the companion animal composition and information that use of the companion animal composition by a companion animal is useful for enhancing total tract digestibility of one or more dietary components in the companion animal, are also disclosed. In a related, but separate, embodiment, a method selected from enhancing calcium absorption, improving bone health, improving strength, improving physical activity performance, and combinations thereof, the method comprising administering to a companion animal a companion animal composition comprising fructooligosaccharide, is disclosed. Kits comprising the companion animal composition and information that use of the companion animal composition by a companion animal is useful for a purpose selected from the group consisting of enhancing calcium absorption, improving bone health, improving strength, improving physical activity performance, and combinations thereof, are also disclosed.
Patent CA-2548040-A1 (CA)
Inventor: REHER THOMAS
IPC: C09D167/08
Filed: 2004-11-25
Abstract: The invention relates to a liquid coating substance which is essentially or completely devoid of corrosion-inhibiting pigments, which can be hardener by actinic radiation, and organic solvents.Said coating substance contains, (A) at least one component selected from the groups comprising low molecular, oligomer and polymer organic compounds which contain at least one group which can be activated by actinic radiation, in addition to air and oxidatively dried alkyd resins, (B) at least one component selected from the groups comprising acidic esters of polyphosphorous acids and monophosphorous acids having at least one compound (b1) containing at least one hydroxyl group and at least one group which can be activated by actinic radiation, and (C) at least one type of nanoparticle. The invention also relates to method for the production and use thereof.
Patent CA-2549922-A1 (CA)
Inventor: YOSHIDA TSUTOMU
IPC: C10L1/04
Filed: 2004-12-16
Abstract: A kerosene composition comprising, in relation to the total composition, at least 99% by weight of n-paraffins and iso-paraffins, which composition has the properties indicated by the following formulae: (A) 6.0~C <= FBP (end point) - 95% distillation point <= 11.0~C; (B) 240~C <= FBP <= 270~C; (C) 150~C <= IBP (initial distillation point) <= 165~C.
Patent CA-2550010-A1 (CA)
Title: Methods for treating retinoid responsive disorders using selective inhibitors of cyp26a and cyp26b
Inventor: YANG RONG
IPC: A61K31/35
Filed: 2004-12-13
Abstract: The invention provides methods for treating an individual having a retinoid responsive disorder. In one embodiment, a method involves administering to the individual an effective amount of a selective CYP26B inhibitor, the selective CYP26B inhibitor having at least 10-fold selectivity for CYP26B relative to CYP26A. In another embodiment, a method involves administering to the individual an effective amount of a selective CYP26A inhibitor, the selective CYP26A inhibitor having a chemical formula set forth in the specification. The invention further provides screening methods for identifying a selective CYP26A inhibitor or selective CYP26B inhibitor.
Patent CA-2551536-A1 (CA)
Title: Tube holder structure of a fluorescent lamp
Inventor: PABST WOLFGANG
IPC: H01J5/48
Filed: 2006-07-04
Abstract: A fluorescent lamp mainly comprises a lamp tube(1), a tube holder(2) and a lamp cap(3), wherein said tube holder(2) has one end fixed to the lamp cap(3) and the other end assembled to the lamp tube(1), characterized in that the walls(2-6) of said tube holder(2) are moved outward in radial direction, thereby substantially circularity gaps(2-3) are formed between the walls(2-6) and the end parts(1-2) of said lamp tube(1), and that said gaps(2-3) are filled with suitable heat insulating material(5) having low heat conduction and resistance to high temperature. An advantage of the present invention is that the hottest parts(2-2) of the tube holder(2) no longer melt and thereby safety is ensured, and that smoke or blackening will not appear any longer. Such fluorescent lamp will enjoy more popularity of the users.
Patent CA-2552435-A1 (CA)
Title: Inhibitors of type 2 vascular endothelial growth factor receptors
Inventor: WRIGHT MARTIN C
IPC: C07K17/00
Filed: 2004-12-06
Abstract: The present disclosure relates to novel vascular endothelial growth factor receptor (VEGFR)-binding polypeptides and methods for using these polypeptides to inhibit biological activities mediated by vascular endothelial growth factors (VEGFs). The present disclosure also provides various improvements relating to single domain binding polypeptides.
Patent CA-2553939-A1 (CA)
Title: Windshield repair apparatus and methods
Inventor: BECKERT ADOLF F
IPC: B60J1/20
Filed: 1995-11-01
Abstract: A windshield repair apparatus and method are provided wherein a quick connect/disconnect bayonet mounting arrangement mounts an injector to a support apparatus which holds the injector relative to a windshield for repair. A ramp surface may be provided with respect to the bayonet mounting arrangement for selective adjustment of the position of the injector relative to the support apparatus. A rubber stopper with two passages is provided with the injector, one passage central to the stopper for receipt of a mechanical probe, and one passage offset from the central passage for receipt of pressures greater than or less than atmospheric pressure during use.
Patent CA-2554923-A1 (CA)
Title: Intervertebral disc prosthesis
Inventor: HOVORKA ISTVAN
IPC: A61F2/30
Filed: 2005-02-04
Abstract: The present invention relates to an intervertebral disc prosthesis comprisin g at least three pieces including an upper plate (1), a lower plate (2) and a mobile core (3) at least relative to the lower plate, the upper surface of t he core being in contact with at least a part of the lower surface of the upper plate, cooperation means (22, 31) limiting or preventing the movements of th e core relative to the lower plate, in translation and in rotation, respectively, along an axis substantially parallel to the lower plate and about an axis substantially perpendicular to the lower plate , characterised in that at least the lower surface of the core has at least one hole (41) facilitating sliding of the core relative to the upper surface of the lower plate with which it is in contact.
Patent CA-2554927-A1 (CA)
Title: Stable amorphous forms of montelukast sodium
Inventor: ADIN ITAI
IPC: C07D215/16
Filed: 2005-02-03
Abstract: An amorphous form of montelukast sodium and a montelukast sodium lactose co-precipitate, processes for producing same, pharmaceutical compositions containing same and methods of treatment utilizing same are disclosed.
Patent CA-2557147-A1 (CA)
Title: A mild body wash
Inventor: WAGNER JULIE ANN
IPC: A61K8/46
Filed: 2005-02-25
Abstract: The present invention relates to a mild body wash composition containing a surfactant component containing a nonionic surfactant having an HLB of from about 1.5 to 13.0, an anionic surfactant, an electrolyte; and the surfactant component has a structured domain.
Patent CA-2559436-A1 (CA)
Title: Materials for treating vascular leakage in the eye
Inventor: RASMUSSEN HENRIK S
IPC: A61P27/02
Filed: 2005-03-11
Abstract: The invention is directed to a method of prophylactically or therapeutically treating an animal for vascular leakage in an eye. The method comprises administering to an animal in need thereof an expression vector comprising a nucleic acid sequence encoding pigment epithelium-derived factor (PEDF) such that vascular leakage in the eye of the animal is treated prophylactically or therapeutically. The invention also provides a method of prophylactically or therapeutically treating an animal for vascular leakage in an eye. The method comprises periocularly administering to an animal in need thereof PEDF such that vascular leakage of the animal is treated prophylactically or therapeutically. The invention also provides a method of prophylactically or therapeutically treating an animal for non-diabetic vascular leakage in an eye. The method comprises administering to an animal in need thereof PEDF such that non-diabetic vascular leakage in the eye is treated prophylactically or therapeutically.
Patent CA-2560623-A1 (CA)
Inventor: DALTON ROBERT E JR
IPC: E05B13/00
Filed: 2006-09-22
Abstract: On divulgue un dispositif de verrouillage, pour utilisation avec des armoires et des panneaux d'accès. Le dispositif de verrouillage comprend une ouverture en forme de trou de serrure dans une partie coulissante de l'ensemble de verrouillage qui coopère avec des protubérances en forme de double D associées à une fiche de blocage. Dans une position verrouillée, les protubérances en forme de double D inhibent le mouvement de la partie coulissante. Dans une position déverrouillée, les éléments en forme de double D peuvent entrer dans une portion plus étroite de l'ouverture en forme de trou de serrure et permettre à la partie coulissante de se déplacer. La partie coulissante est associée à des caractéristiques supplémentaires pour que le mouvement de la partie coulissante inhibe sélectivement ou permette des mouvements consécutifs d'autres éléments qui, à leur tour, nient ou créent respectivement un accès à une armoire.
Patent CA-2560885-A1 (CA)
Title: Prosthetic foot with tunable performance
Inventor: CLAUDINO BYRON K
IPC: A61F2/70
Filed: 2005-03-30
Abstract: A prosthetic foot (124) incorporates a foot keel (165) and a calf shank (126) connected to the foot keel to form an ankle joint area of the prosthetic foot.  A device (125) connected between the upper end of the calf shank and the lower portion of the prosthesis can be used to assist posterior movement of the upper end of a calf shank and control anterior movement of the upper end of the calf shank during use of the prosthesis. The device (125) has springs which store energy during force loading with anterior motion of the upper end of the calf shank in gait and which, during force unloading, return the stored energy as kinetic power for adding to the propulsive force on the user's body generated by the prosthesis in gait.
Patent CA-2562620-A1 (CA)
Inventor: EATON ROBERT B
IPC: G01S17/87
Filed: 2006-10-05
Abstract: An apparatus for measuring distance to a surface is disclosed. The apparatus transmits at least one subsequent pulse of light prior to receiving a reflection of a previously sent pulse of light. Thus, multiple pulses of light are in-flight at a given time. The embodiments are applicable to terrain mapping, bathymetry, seismology, detecting faults, biomass measurement, wind speed measurement, temperature calculation, traffic speed measurement, military target identification, surface to air rangefinding, high definition survey, close range photogrammetry, atmospheric composition, meteorology, distance measurement, as well as many other applications.  Examples of such apparatuses include laser ranging systems, such as light detection and ranging (LIDAR) systems, and laser scanners. Data received from the apparatus by a data processing unit can be used to create a data model, such as a point cloud, digital surface model or digital terrain model describing the surface, terrain, and/or objects.
Patent CA-2565923-A1 (CA)
Inventor: PETIT-CONIL MICHEL
IPC: D21C5/00
Filed: 2005-05-03
Abstract: A method of producing hardwood pulp is provided. This method comprises treating hardwood chips with one or more than one Family 11 xylanase enzyme in the absence of adding an oxidizing enzyme for about 5 minutes to about 120 minutes, to produce a treated chip mixture. The treated chip mixture is then mechanically refined to produce the hardwood pulp.
Patent CA-2566336-A1 (CA)
Title: Sequences d'adn pour la detection de et la differenciation entre des e.coli pathogenes
Inventor: BURNS FRANK R
IPC: C12Q1/68
Filed: 2005-06-24
Abstract: L'invention concerne des séquences d'oligonucléotides et des méthodes de détection et de différenciation spécifiques entre desE.coli pathogènes dans un échantillon complexe. L'échantillon complexe peut être un échantillon alimentaire, un échantillon d'eau ou une matrice d'aliments enrichie sélectivement. Les méthodes de détection peuvent utiliser une amplification ACP avec ou sans témoin positif interne ainsi que des paires d'amorces appropriées. Des réactifs de mise en application des méthodes peuvent être fournis sous la forme d'un kit et/ou de pastilles.
Patent CA-2566708-A1 (CA)
Title: Pneumatic tyre
Inventor: HUMAN JAN PETRUS
IPC: B60C11/02
Filed: 2005-05-11
Abstract: The invention relates to a pneumatic tyre which comprises first (10) and second (12) separable tyre parts, the first tyre part including the tyre's side walls and the inner layer of the tyre's crown and having reinforcing plies in it, and the second tyre part encircling the first tyre part and having the tread pattern (14) therein. The said second tyre part (12) further has beads (22) along both peripheries thereof, said beads being outwardly of said side walls of said first tyre part (10).
Patent CA-2566894-A1 (CA)
Title: Wind power installation having an auxiliary generator and method for the control thereof
Inventor: VOSS EBERHARD
IPC: F03D7/02
Filed: 2005-05-13
Abstract: The invention relates to a wind power installation comprising a rotor, a generator for generating electric power, at least one rotationally mounted rotor blade that can be displaced about its longitudinal axis in order to adjust the angle of attack and an auxiliary generator for generating electric power for at least one consumer. The invention is characterized in that the auxiliary generator generates electric power in a rotational speed range that is lower than in normal operating mode for the control mechanism controlling rotor blade adjustment and for a drive mechanism for adjusting the angle of attack of the at least one rotor blade, wherein the control mechanism controls or adjusts the angle of attack for permanent operation in the rotational speed range.
Patent CA-2567310-A1 (CA)
Inventor: DEL RIO ALESSANDRA
IPC: A61K38/21
Filed: 2005-05-27
Abstract: A stabilized HSA-free liquid pharmaceutical composition is described, which comprises an interferon (IFN), wherein said formulation is a solution that comprises a buffer, an amino acid and an antioxidant. Preferably the interferon is human recombinant IFN-beta.
Patent CA-2567553-A1 (CA)
Title: System and method for disseminating color ink and colorant formulas
Inventor: RICH DANNY
IPC: G05B19/042
Filed: 2005-05-20
Abstract: The present invention provides a plurality of representations of color that are stored in an electronic color library and that can be selected by a user.  After a color selection is made, a plurality of color ink formulas and/or colorant formulas capable of producing the selected color are provided.  Further, other selections can be made to define a substrate or other criteria that can impact the color ink formulas. The user can make a selection among the plurality of color ink formulas and/or colorant formulas. The selected color ink formulas) (or colorant formula(s)) can be transmitted over a communication network, such as the Internet or a local Intranet to another party, such as an ink manufacturer.
Patent CA-2568207-A1 (CA)
Title: Glaucoma shunt
Inventor: PRESCOTT ANTHONY D
IPC: A61M5/00
Filed: 2005-05-25
Abstract: A glaucoma shunt includes a plate having filtration and fixation portions. In some embodiments the filtration portion includes a surface provided with stiffening ribs which increase rigidity and an upper surface provided with a ridge. The fixation portion extends anteriorly to facilitate access thereto. A  drainage tube is recessed within the plate and extends through the ridge to a central portion of the filtration portion. By emptying the tube at the central portion of the filtration portion, the tube outlet is distanced from perimetric scar tissue which can otherwise obstruct the tube outlet. The ridge keeps tissue over the plate spaced from the outlet of the tube to further facilitate drainage.
Patent CA-2569832-A1 (CA)
Title: Manufacture of cadmium mercury telluride on patterned silicon
Inventor: PRYCE GRAHAM JOHN
IPC: H01L27/146
Filed: 2005-08-01
Abstract: This invention relates to the manufacture of Cadmium Mercury Telluride (CMT) on patterned silicon, especially to growth of CMT on silicon substrates bearing integrated circuitry. The method of the invention involves growing ! "  in selected growth windows on the silicon substrate by first growing one or more buffer layers by MBE and then growing the CM" by MOVPE. The growth windows may be defined by masking the area outside of the growth windows.  Growth within the growth windows is crystalline whereas any growth outside the growth windows is polycrystalline and can be removed by etching. The invention offers a method of growing CMT structures directly on integrated circuits removing the need for hybridisation.
Patent CA-2570392-A1 (CA)
Title: Peptide vaccine for cancer therapy
Inventor: ITOH KYOGO
IPC: A61P35/00
Filed: 2005-06-21
Abstract: A method for treating a cancer patient involving the administration of a therapeutically effective amount of cancer antigens to a patient requiring the same, characterized by comprising: 1) providing a set of cancer antigen peptides consisting of two or more cancer antigen peptides; 2) evaluating the presence or absence of specific cytotoxic T lymphocyte precursors for individual peptides contained in the cancer antigen peptide set in the patient; 3) removing a cancer antigen peptide, concerning which the patient is evaluated as having no cytotoxic T lymphocyte precursor specific thereto, from the cancer antigen peptide set to thereby prepare a cancer antigen peptide set for administration; and 4) administering the cancer antigen peptide set to the patient.
Patent CA-2571593-A1 (CA)
Inventor: DEERE JESSE D
IPC: C12N15/113
Filed: 2005-07-01
Abstract: A method and antisense compound for inhibiting the growth of pathogenic bacterial cells are disclosed. The compound contains no more than 12 nucleotide bases and has a targeting nucleic acid sequence of no fewer than 10 bases in length that is complementary to a target sequence containing or within 10 bases, in a downstream direction, of the translational start codon of a bacterial mRNA that encodes a bacterial protein essential for bacterial replication. The compound binds to a target mRNA with a Tm of between 50 ~C to 60 ~C. The relatively short antisense compound are substantially more active than conventional antisense compounds having a targeting base sequence of 15 or more bases.
Patent CA-2572052-A1 (CA)
Inventor: SATO KAORU
IPC: G10L19/16
Filed: 2005-06-16
Abstract: There is disclosed an audio encoding device capable of realizing effective encoding while using audio encoding of the CELP method in an extended layer when hierarchically encoding an audio signal. In this device, a first encoding unit (115) subjects an input signal (S11) to audio encoding processing of the CELP method and outputs the obtained first encoded information (S12) to a parameter decoding unit (120). The parameter decoding unit (120) acquires a first quantization LSP code (L1), a first adaptive sound source lag code (A1), and the like from the first encoded information (S12), obtains a first parameter group (S13) from these codes, and outputs it to a second encoding unit (130). The second encoding unit (130) subjects the input signal (S11) to a second encoding processing by using the first parameter group (S13) and obtains second encoded information (S14). A multiplexing unit (154) multiplexes the first encoded information (S12) with the second encoded information (S14) and outputs them via a transmission path N to a decoding device (150).